Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Philip Scott Zeitler

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PEDS
Phone720/777-6128

    Collapse Research 
    Collapse research activities and funding
    F32HD007239     (ZEITLER, PHILIP S)Mar 23, 1989
    NIH/NICHD
    REGULATION OF SOMATOSTATIN GENE EXPRESSION IN VITRO
    Role: Principal Investigator

    U01DK061242     (ZEITLER, PHILIP S)Sep 30, 2001 - Feb 28, 2010
    NIH/NIDDK
    Treatment Alternatives in Pediatric Type 2 Diabetes
    Role: Principal Investigator

    U01DK061230     (DREWS, KIMBERLY LEE)Sep 30, 2001 - Apr 30, 2020
    NIH/NIDDK
    TODAY2 Phase 2 (T2P2): Long-Term Post-Intervention Follow-Up
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Chan CL, Pyle L, Kelsey MM, Newnes L, Baumgartner A, Zeitler PS, Nadeau KJ. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes. Pediatr Diabetes. 2016 Nov 22. PMID: 27873436.
      View in: PubMed
    2. Davis SM, Cox-Martin M, Bardsley M, Kowal K, Zeitler PS, Ross JL. Effects of Oxandrolone on Cardiometabolic Health in Boys with Klinefelter syndrome: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2016 Nov 01; jc20162904. PMID: 27802097.
      View in: PubMed
    3. Davis S, Lahlou N, Bardsley M, Temple MC, Kowal K, Pyle L, Zeitler P, Ross J. Gonadal function is associated with cardiometabolic health in pre-pubertal boys with Klinefelter syndrome. Andrology. 2016 Nov; 4(6):1169-1177. PMID: 27637014.
      View in: PubMed
    4. Davis S, Howell S, Wilson R, Tanda T, Ross J, Zeitler P, Tartaglia N. Advances in the Interdisciplinary Care of Children with Klinefelter Syndrome. Adv Pediatr. 2016 Aug; 63(1):15-46. PMID: 27426894.
      View in: PubMed
    5. Gandica R, Zeitler P. Update on Youth-Onset Type 2 Diabetes: Lessons Learned from the Treatment Options for Type 2 Diabetes in Adolescents and Youth Clinical Trial. Adv Pediatr. 2016 Aug; 63(1):195-209. PMID: 27426901.
      View in: PubMed
    6. Marcus MD, Wilfley DE, El Ghormli L, Zeitler P, Linder B, Hirst K, Ievers-Landis CE, van Buren DJ, Walders-Abramson N. Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience. Pediatr Obes. 2016 May 10. PMID: 27161901.
      View in: PubMed
    7. Zeitler P, Hirst K, Copeland KC, El Ghormli L, Levitt Katz L, Levitsky LL, Linder B, McGuigan P, White NH, Wilfley D. HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes. Diabetes Care. 2015 Dec; 38(12):2285-92. PMID: 26537182.
      View in: PubMed
    8. Tartaglia N, Howell S, Wilson R, Janusz J, Boada R, Martin S, Frazier JB, Pfeiffer M, Regan K, McSwegin S, Zeitler P. The eXtraordinarY Kids Clinic: an interdisciplinary model of care for children and adolescents with sex chromosome aneuploidy. J Multidiscip Healthc. 2015; 8:323-34. PMID: 26229481.
      View in: PubMed
    9. Weinstock RS, Drews KL, Caprio S, Leibel NI, McKay SV, Zeitler PS. Metabolic syndrome is common and persistent in youth-onset type 2 diabetes: Results from the TODAY clinical trial. Obesity (Silver Spring). 2015 Jul; 23(7):1357-61. PMID: 26047470.
      View in: PubMed
    10. Zeitler P, Chou HS, Copeland KC, Geffner M. Clinical trials in youth-onset type 2 diabetes: needs, barriers, and options. Curr Diab Rep. 2015 May; 15(5):28. PMID: 25777998.
      View in: PubMed
    11. Chan CL, Pyle L, Kelsey M, Newnes L, Zeitler PS, Nadeau KJ. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin. Pediatr Diabetes. 2016 May; 17(3):206-11. PMID: 25652226.
      View in: PubMed
    12. Chan CL, Pyle L, Newnes L, Nadeau KJ, Zeitler PS, Kelsey MM. Continuous glucose monitoring and its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic youth. J Clin Endocrinol Metab. 2015 Mar; 100(3):902-10. PMID: 25532041.
      View in: PubMed
    13. Zeitler P, Fu J, Tandon N, Nadeau K, Urakami T, Barrett T, Maahs D. ISPAD Clinical Practice Consensus Guidelines 2014. Type 2 diabetes in the child and adolescent. Pediatr Diabetes. 2014 Sep; 15 Suppl 20:26-46. PMID: 25182306.
      View in: PubMed
    14. Chan CL, McFann K, Newnes L, Nadeau KJ, Zeitler PS, Kelsey M. Hemoglobin A1c assay variations and implications for diabetes screening in obese youth. Pediatr Diabetes. 2014 Dec; 15(8):557-63. PMID: 24636682.
      View in: PubMed
    15. Lauro C, Macy ME, Zeitler P, Backus J, Mettler P, Foreman N, Liu AK. The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation. J Pediatr Endocrinol Metab. 2014 Mar; 27(3-4):299-303. PMID: 24057590.
      View in: PubMed
    16. Walders-Abramson N, Nadeau KJ, Kelsey MM, Schmiege SJ, Ellert S, Cejka A, Bhatnagar K, Zeitler P. Psychological functioning in adolescents with obesity co-morbidities. Child Obes. 2013 Aug; 9(4):319-25. PMID: 23763659.
      View in: PubMed
    17. Love-Osborne KA, Sheeder J, Svircev A, Chan C, Zeitler P, Nadeau KJ. Use of glycosylated hemoglobin increases diabetes screening for at-risk adolescents in primary care settings. Pediatr Diabetes. 2013 Nov; 14(7):512-8. PMID: 23659706.
      View in: PubMed
    18. Chan CL, McFann K, Taylor L, Wright D, Zeitler PS, Barker JM. Congenital adrenal hyperplasia and the second newborn screen. J Pediatr. 2013 Jul; 163(1):109-13.e1. PMID: 23414665.
      View in: PubMed
    19. Kapadia C, Zeitler P. Hemoglobin A1c measurement for the diagnosis of Type 2 diabetes in children. Int J Pediatr Endocrinol. 2012 Dec 20; 2012(1):31. PMID: 23256825.
      View in: PubMed
    20. Sundaram SS, Alonso EM, Zeitler P, Yin W, Anand R. Obesity after pediatric liver transplantation: prevalence and risk factors. J Pediatr Gastroenterol Nutr. 2012 Dec; 55(6):657-62. PMID: 22744193.
      View in: PubMed
    21. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012 Jun 14; 366(24):2247-56. PMID: 22540912.
      View in: PubMed
    22. Nadeau K, Kolotkin RL, Boex R, Witten T, McFann KK, Zeitler P, Walders-Abramson N. Health-related quality of life in adolescents with comorbidities related to obesity. J Adolesc Health. 2011 Jul; 49(1):90-2. PMID: 21700164.
      View in: PubMed
    23. Tartaglia N, Ayari N, Howell S, D'Epagnier C, Zeitler P. 48,XXYY, 48,XXXY and 49,XXXXY syndromes: not just variants of Klinefelter syndrome. Acta Paediatr. 2011 Jun; 100(6):851-60. PMID: 21342258.
      View in: PubMed
    24. Hobernicht SL, Schweiger B, Zeitler P, Wang M, Hunger SP. Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy. Pediatr Blood Cancer. 2011 Apr; 56(4):671-3. PMID: 21298759.
      View in: PubMed
    25. Zeitler P. Approach to the obese adolescent with new-onset diabetes. J Clin Endocrinol Metab. 2010 Dec; 95(12):5163-70. PMID: 21131537.
      View in: PubMed
    26. Moriarty-Kelsey M, Harwood JE, Travers SH, Zeitler PS, Nadeau KJ. Testosterone, obesity and insulin resistance in young males: evidence for an association between gonadal dysfunction and insulin resistance during puberty. J Pediatr Endocrinol Metab. 2010 Dec; 23(12):1281-7. PMID: 21714462.
      View in: PubMed
    27. Zeitler P, Haqq A, Rosenbloom A, Glaser N. Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment. J Pediatr. 2011 Jan; 158(1):9-14, 14.e1-2. PMID: 21035820.
      View in: PubMed
    28. Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, Kaufman FR, Linder B, Marcovina S, McGuigan P, Pyle L, Tamborlane W, Willi S. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab. 2011 Jan; 96(1):159-67. PMID: 20962021.
      View in: PubMed
    29. Schweiger B, Zeitler P, Eppley S, Swietlik M, Barker J. Using the electronic medical record to improve education in patients at risk for adrenal insufficiency. Int J Pediatr Endocrinol. 2010; 2010. PMID: 20706687.
      View in: PubMed
    30. Zeitler P, Solberg P. Food and levothyroxine administration in infants and children. J Pediatr. 2010 Jul; 157(1):13-14.e1. PMID: 20547262.
      View in: PubMed
    31. Zeitler P. Considerations regarding the diagnosis and treatment of childhood type 2 diabetes. Postgrad Med. 2010 May; 122(3):89-97. PMID: 20463418.
      View in: PubMed
    32. Nadeau KJ, Regensteiner JG, Bauer TA, Brown MS, Dorosz JL, Hull A, Zeitler P, Draznin B, Reusch JE. Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab. 2010 Feb; 95(2):513-21. PMID: 19915016.
      View in: PubMed
    33. Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ. Type 2 diabetes in children and adolescents. Pediatr Diabetes. 2009 Sep; 10 Suppl 12:17-32. PMID: 19754615.
      View in: PubMed
    34. Sundaram SS, Zeitler P, Nadeau K. The metabolic syndrome and nonalcoholic fatty liver disease in children. Curr Opin Pediatr. 2009 Aug; 21(4):529-35. PMID: 19444112.
      View in: PubMed
    35. Nadeau KJ, Zeitler PS, Bauer TA, Brown MS, Dorosz JL, Draznin B, Reusch JE, Regensteiner JG. Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity. J Clin Endocrinol Metab. 2009 Oct; 94(10):3687-95. PMID: 19584191.
      View in: PubMed
    36. Zeitler P. Update on nonautoimmune diabetes in children. J Clin Endocrinol Metab. 2009 Jul; 94(7):2215-20. PMID: 19584196.
      View in: PubMed
    37. Taplin CE, Zeitler P. Exercise for the treatment of childhood obesity--is it simply too much to ask? Acta Paediatr. 2009 Feb; 98(2):214-6. PMID: 19143663.
      View in: PubMed
    38. Zeitler PS, Klingensmith GJ. They're still kids. J Pediatr. 2009 Jan; 154(1):7-9. PMID: 19187730.
      View in: PubMed
    39. Roman R, Zeitler PS. Oral glucose tolerance testing in asymptomatic obese children: more questions than answers. J Clin Endocrinol Metab. 2008 Nov; 93(11):4228-30. PMID: 18987283.
      View in: PubMed
    40. West NA, Hamman RF, Mayer-Davis EJ, D'Agostino RB, Marcovina SM, Liese AD, Zeitler PS, Daniels SR, Dabelea D. Cardiovascular risk factors among youth with and without type 2 diabetes: differences and possible mechanisms. Diabetes Care. 2009 Jan; 32(1):175-80. PMID: 18945923.
      View in: PubMed
    41. Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Type 2 diabetes mellitus in the child and adolescent. Pediatr Diabetes. 2008 Oct; 9(5):512-26. PMID: 18694453.
      View in: PubMed
    42. Nadeau KJ, Ehlers LB, Zeitler PS, Love-Osborne K. Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents. Pediatr Diabetes. 2009 Feb; 10(1):5-13. PMID: 18721166.
      View in: PubMed
    43. Nadeau K, Zeitler PS. A boost to the study of insulin secretion in children and adolescents. J Pediatr. 2008 May; 152(5):603-4. PMID: 18410758.
      View in: PubMed
    44. Dabelea D, Mayer-Davis EJ, Lamichhane AP, D'Agostino RB, Liese AD, Vehik KS, Narayan KM, Zeitler P, Hamman RF. Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study. Diabetes Care. 2008 Jul; 31(7):1422-6. PMID: 18375420.
      View in: PubMed
    45. Love-Osborne K, Sheeder J, Zeitler P. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance. J Pediatr. 2008 Jun; 152(6):817-22. PMID: 18492523.
      View in: PubMed
    46. Love-Osborne KA, Nadeau KJ, Sheeder J, Fenton LZ, Zeitler P. Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease. J Adolesc Health. 2008 Jun; 42(6):543-8. PMID: 18486862.
      View in: PubMed
    47. Rauch F, Plotkin H, DiMeglio L, Engelbert RH, Henderson RC, Munns C, Wenkert D, Zeitler P. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions. J Clin Densitom. 2008 Jan-Mar; 11(1):22-8. PMID: 18442750.
      View in: PubMed
    48. Zeitler P, Pinhas-Hamiel O. Prevention and screening for type 2 diabetes in youth. Endocr Res. 2008; 33(1-2):73-91. PMID: 19156575.
      View in: PubMed
    49. Pinhas-Hamiel O, Zeitler P. Clinical presentation and treatment of type 2 diabetes in children. Pediatr Diabetes. 2007 Dec; 8 Suppl 9:16-27. PMID: 17991129.
      View in: PubMed
    50. Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet. 2007 May 26; 369(9575):1823-31. PMID: 17531891.
      View in: PubMed
    51. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes. 2007 Apr; 8(2):74-87. PMID: 17448130.
      View in: PubMed
    52. Zeitler P. Editorial: School-based intervention to reduce obesity and diabetes risks: small steps for a big problem. J Clin Endocrinol Metab. 2007 Feb; 92(2):422-4. PMID: 17284645.
      View in: PubMed
    53. Simmons J, Zeitler P, Steelman J. Advances in the diagnosis and treatment of osteoporosis. Adv Pediatr. 2007; 54:85-114. PMID: 17918468.
      View in: PubMed
    54. Love-Osborne K, Butler N, Gao D, Zeitler P. Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes. Pediatr Diabetes. 2006 Aug; 7(4):205-10. PMID: 16911007.
      View in: PubMed
    55. Siriwardana G, Bradford A, Coy D, Zeitler P. Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. Mol Endocrinol. 2006 Sep; 20(9):2010-9. PMID: 16613992.
      View in: PubMed
    56. Pinhas-Hamiel O, Chernausek SD, Zeitler P. Acute necrotizing pancreatitis in an adolescent with type 2 diabetes. Curr Opin Pediatr. 2006 Apr; 18(2):206-8. PMID: 16601505.
      View in: PubMed
    57. Maniatis AK, Taylor L, Letson GW, Bloch CA, Kappy MS, Zeitler P. Congenital hypothyroidism and the second newborn metabolic screening in Colorado, USA. J Pediatr Endocrinol Metab. 2006 Jan; 19(1):31-8. PMID: 16509526.
      View in: PubMed
    58. Simmons JH, Zeitler PS, Fenton LZ, Abzug MJ, Fiallo-Scharer RV, Klingensmith GJ. Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the literature. Pediatr Diabetes. 2005 Dec; 6(4):234-8. PMID: 16390393.
      View in: PubMed
    59. Nadeau KJ, Klingensmith G, Zeitler P. Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr. 2005 Jul; 41(1):94-8. PMID: 15990637.
      View in: PubMed
    60. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005 May; 146(5):693-700. PMID: 15870677.
      View in: PubMed
    61. Maniatis AK, Simmons JH, Zeitler PS. Hypothalamic obesity in a patient with craniopharyngioma: dysregulation of neurohormonal control of energy balance. Curr Opin Pediatr. 2005 Apr; 17(2):275-9. PMID: 15800425.
      View in: PubMed
    62. Pinhas-Hamiel O, Zeitler P. Advances in epidemiology and treatment of type 2 diabetes in children. Adv Pediatr. 2005; 52:223-59. PMID: 16124343.
      View in: PubMed
    63. Steelman J, Zeitler P. Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions. J Pediatr. 2003 Apr; 142(4):417-23. PMID: 12712060.
      View in: PubMed
    64. Pinhas-Hamiel O, Zeitler P. Barriers to the treatment of adolescent type 2 diabetes--a survey of provider perceptions. Pediatr Diabetes. 2003 Mar; 4(1):24-8. PMID: 14655520.
      View in: PubMed
    65. Zeitler P, Siriwardana G. Antagonism of endogenous growth hormone-releasing hormone (GHRH) leads to reduced proliferation and apoptosis in MDA231 breast cancer cells. Endocrine. 2002 Jun; 18(1):85-90. PMID: 12166629.
      View in: PubMed
    66. Steelman J, Zeitler P. Osteoporosis in pediatrics. Pediatr Rev. 2001 Feb; 22(2):56-65. PMID: 11157102.
      View in: PubMed
    67. Pinhas-Hamiel O, Zeitler P. "Who is the wise man?--The one who foresees consequences:". Childhood obesity, new associated comorbidity and prevention. Prev Med. 2000 Dec; 31(6):702-5. PMID: 11133337.
      View in: PubMed
    68. Covar RA, Leung DY, McCormick D, Steelman J, Zeitler P, Spahn JD. Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma. J Allergy Clin Immunol. 2000 Oct; 106(4):651-9. PMID: 11031335.
      View in: PubMed
    69. Zeitler P, Siriwardana G. Stimulation of mitogen-activated protein kinase pathway in rat somatotrophs by growth hormone-releasing hormone. Endocrine. 2000 Jun; 12(3):257-64. PMID: 10963046.
      View in: PubMed
    70. Pinhas-Hamiel O, Standiford D, Hamiel D, Dolan LM, Cohen R, Zeitler PS. The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus. Arch Pediatr Adolesc Med. 1999 Oct; 153(10):1063-7. PMID: 10520614.
      View in: PubMed
    71. Zeitler P. A rose is a rose is a rose--or is it? J Pediatr. 1999 Aug; 135(2 Pt 1):142-4. PMID: 10431105.
      View in: PubMed
    72. Pinhas-Hamiel O, Zeitler P. Clinical problem-solving. The importance of a name. N Engl J Med. 1999 May 06; 340(18):1418-21. PMID: 10228194.
      View in: PubMed
    73. Zeitler PS, Travers S, Kappy MS. Advances in the recognition and treatment of endocrine complications in children with chronic illness. Adv Pediatr. 1999; 46:101-49. PMID: 10645463.
      View in: PubMed
    74. Zeitler P, Stevens P, Siriwardana G. Functional GHRH receptor carboxyl terminal isoforms in normal and dwarf (dw) rats. J Mol Endocrinol. 1998 Dec; 21(3):363-71. PMID: 9845677.
      View in: PubMed
    75. Pinhas-Hamiel O, Zeitler P. Type 2 diabetes in adolescents, no longer rare. Pediatr Rev. 1998 Dec; 19(12):434-5. PMID: 9849077.
      View in: PubMed
    76. Tannenbaum GS, Zhang WH, Lapointe M, Zeitler P, Beaudet A. Growth hormone-releasing hormone neurons in the arcuate nucleus express both Sst1 and Sst2 somatostatin receptor genes. Endocrinology. 1998 Mar; 139(3):1450-3. PMID: 9492082.
      View in: PubMed
    77. Pinhas-Hamiel O, Dolan LM, Zeitler PS. Diabetic ketoacidosis among obese African-American adolescents with NIDDM. Diabetes Care. 1997 Apr; 20(4):484-6. PMID: 9096965.
      View in: PubMed
    78. Pinhas-Hamiel O, Zeitler P. Insulin resistance, obesity, and related disorders among black adolescents. J Pediatr. 1996 Sep; 129(3):319-20. PMID: 8804318.
      View in: PubMed
    79. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr. 1996 May; 128(5 Pt 1):608-15. PMID: 8627431.
      View in: PubMed
    80. Korytko AI, Zeitler P, Cuttler L. Developmental regulation of pituitary growth hormone-releasing hormone receptor gene expression in the rat. Endocrinology. 1996 Apr; 137(4):1326-31. PMID: 8625907.
      View in: PubMed
    81. Li H, Zeitler PS, Valerius MT, Small K, Potter SS. Gsh-1, an orphan Hox gene, is required for normal pituitary development. EMBO J. 1996 Feb 15; 15(4):714-24. PMID: 8631293.
      View in: PubMed
    82. Zeitler P. Delay in diagnosis of congenital adrenal hyperplasia in an acutely ill infant. The confounding effect of unrelated medical therapies. Clin Pediatr (Phila). 1995 Nov; 34(11):603-4. PMID: 8565391.
      View in: PubMed
    83. Markoff E, Henemyre C, Fellows J, Pennington E, Zeitler PS, Cedars MI. Localization of insulin-like growth factor binding protein-4 expression in the mouse uterus during the peri-implantation period. Biol Reprod. 1995 Nov; 53(5):1103-9. PMID: 8527514.
      View in: PubMed
    84. Zeitler P, Downs TR, Frohman LA. Impaired growth hormone-releasing hormone signal transduction in the dwarf (dw) rat is independent of a generalized defect in the stimulatory G-protein, Gs alpha. Endocrinology. 1993 Dec; 133(6):2782-6. PMID: 8243305.
      View in: PubMed
    85. Chua SC, Hennessey K, Zeitler P, Leibel RL. The little (lit) mutation cosegregates with the growth hormone releasing factor receptor on mouse chromosome 6. Mamm Genome. 1993; 4(10):555-9. PMID: 8268652.
      View in: PubMed
    86. Zeitler P, Tannenbaum GS, Clifton DK, Steiner RA. Ultradian oscillations in somatostatin and growth hormone-releasing hormone mRNAs in the brains of adult male rats. Proc Natl Acad Sci U S A. 1991 Oct 15; 88(20):8920-4. PMID: 1681547.
      View in: PubMed
    87. Argente J, Chowen JA, Zeitler P, Clifton DK, Steiner RA. Sexual dimorphism of growth hormone-releasing hormone and somatostatin gene expression in the hypothalamus of the rat during development. Endocrinology. 1991 May; 128(5):2369-75. PMID: 1673430.
      View in: PubMed
    88. Zeitler P, Wu YQ, Handwerger S. Melittin stimulates phosphoinositide hydrolysis and placental lactogen release: arachidonic acid as a link between phospholipase A2 and phospholipase C signal-transduction pathways. Life Sci. 1991; 48(21):2089-95. PMID: 1851918.
      View in: PubMed
    89. Tannenbaum GS, McCarthy GF, Zeitler P, Beaudet A. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus. Endocrinology. 1990 Nov; 127(5):2551-60. PMID: 1977581.
      View in: PubMed
    90. Zeitler P, Vician L, Chowen-Breed JA, Argente J, Tannenbaum GS, Clifton DK, Steiner RA. Regulation of somatostatin and growth hormone-releasing hormone gene expression in the rat brain. Metabolism. 1990 Sep; 39(9 Suppl 2):46-9. PMID: 1976220.
      View in: PubMed
    91. Zeitler P, Argente J, Chowen-Breed JA, Clifton DK, Steiner RA. Growth hormone-releasing hormone messenger ribonucleic acid in the hypothalamus of the adult male rat is increased by testosterone. Endocrinology. 1990 Sep; 127(3):1362-8. PMID: 2117526.
      View in: PubMed
    92. Harman I, Zeitler P, Ganong B, Bell RM, Handwerger S. Sn-1,2-diacylglycerols and phorbol esters stimulate the synthesis and release of human placental lactogen from placental cells: a role for protein kinase C. Endocrinology. 1986 Sep; 119(3):1239-44. PMID: 3732165.
      View in: PubMed
    93. Zeitler P, Murphy E, Handwerger S. Arachidonic acid stimulates 45calcium efflux and hPL release in isolated trophoblast cells. Life Sci. 1986 Jan 13; 38(2):99-107. PMID: 3080649.
      View in: PubMed
    94. Zeitler P, Handwerger S. Arachidonic acid stimulates phosphoinositide hydrolysis and human placental lactogen release in an enriched fraction of placental cells. Mol Pharmacol. 1985 Dec; 28(6):549-54. PMID: 3001498.
      View in: PubMed
    95. Zeitler P, Markoff E, Handwerger S. Characterization of the synthesis and release of human placental lactogen and human chorionic gonadotropin by an enriched population of dispersed placental cells. J Clin Endocrinol Metab. 1983 Oct; 57(4):812-8. PMID: 6309887.
      View in: PubMed
    96. Markoff E, Zeitler P, Peleg S, Handwerger S. Characterization of the synthesis and release of prolactin by an enriched fraction of human decidual cells. J Clin Endocrinol Metab. 1983 May; 56(5):962-8. PMID: 6300179.
      View in: PubMed
    97. Handwerger S, Barry S, Barrett J, Markoff E, Zeitler P, Cwikel B, Siegel M. Inhibition of the synthesis and secretion of decidual prolactin by arachidonic acid. Endocrinology. 1981 Dec; 109(6):2016-21. PMID: 6796386.
      View in: PubMed
    98. Handwerger S, Barrett J, Barry S, Markoff E, Zeitler P, Cwikel B, Siegel M. Stimulation of human placental lactogen release by arachidonic acid. Mol Pharmacol. 1981 Nov; 20(3):609-13. PMID: 6799774.
      View in: PubMed
    Zeitler's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)